Guo Peixuan, born in Shantou, Guangdong province, graduated from Foshan University in veterinary in 1978 and in 1982, he received a master’s degree of science from South China Agricultural College. In 1984, Guo was enrolled in the University of Minnesota and received a doctorate degree in microbiology and genetics in 1987.
After graduation, Guo completed his post-doc research at NIH in 1990, and then he served as a professor at Purdue University. In 2007, Guo held the Dane & Mary Louise Miller Endowed Chair in Biomedical Engineering and was director of the NIH Nanomedicine Development Center and professor in the Department of Biomedical Engineering at the University of Cincinnati. Since 2012, Guo has served as a professor in the College of Parmacy’s Department of Pharmaceutical Scieneces and held the William S. Farish Fund Endowed Chair in Nanobiotechnology for the University of Kentucky Markey Cancer Center.
Currently, Guo serve as visiting professors and consultant for many Chinese institutions of higher education and research organizations, such as Zhejiang University, Huazhong University of Science and Technology, Institute of Microbiology at Chinese Academy of Sciences, etc.
Guo has achieved extraordinary academic achievements, and is considered as one of the top three nanobiotechnology experts in the world. At the same time, Guo is also an excellent entrepreneur, and is the founder of two biotechnology companies including Kylin Therapeutics, Inc.
Guo has received many honors and awards. He received the NIH First Award in 1993, the Pfizer Distinguished Faculty Award in 1995, Purdue Faculty Scholar Award in 1998, Feynman Prize in Nanotechnology in 2005, and Distinguished Research Alumnus award from the University of Minnesota in 2009.